Funding for this research was provided by:
Kom op tegen Kanker (00000000010000000327)
Received: 22 July 2019
Accepted: 26 August 2019
First Online: 4 September 2019
Ethics approval and consent to participate
: The trial will be conducted in compliance with the principles of the Declaration of Helsinki (64th WMA General Assembly, Fortaleza, Brazil, October 2013), the principles of good clinical practice and all of the applicable regulatory requirements. The study protocol received approval of the Ethics Committee of the GZA Hospitals, Belgium on September 4th 2018. Any subsequent protocol amendment will be submitted to the Ethics Committee for approval. The Clinical Trials Oncology trial unit of the GZA hospitals will conduct the trial and has ISO 9001 quality certificate since 18th April 2013. Written informed consent from patients is mandatory before recruitment.
: Not applicable.
: The authors declare that they have no competing interests.